CANCER IS OUR CAUSE
U.S. FDA approves new indication
Our flagship medicine is now available for certain patients with previously treated advanced neuroendocrine tumors.
Read Our Press Release
Patients are at the center of everything we do
Dusty’s journey with neuroendocrine tumors highlights the power of advocacy and community.
Watch Dusty’s Story
Advancing our pipeline
Learn about our first pivotal trial in squamous cell carcinoma of the head and neck.
Read Our News
An exceptional employee experience
Experience more purposeful work and fulfilling opportunities.
See Open Jobs
Accelerating our impact in oncology
Develop next-generation cancer medicines with us.
Let’s Collaborate
Supporting our community
We are champions for causes we believe in.
See Our Impact
Inspired by science
Leveraging deep expertise in chemistry and biology, as well as strategic partnerships, we are advancing various biotherapeutics that have the potential to become anti-cancer therapies, such as bispecific antibodies, antibody-drug conjugates and other innovative treatments.
Our discovery teams are advancing multiple small molecule programs internally and through our industry collaborations.
Our R&D programs include next-generation approaches to established targets, as well as opportunities to be first-in-class by applying a range of modalities and mechanisms of action across biologics and small molecules.
Powered by innovation and hope
At Exelixis, cancer is our cause. Over the course of the past three decades, we’ve evolved into a multi-platform cancer company dedicated to creating treatment regimens that challenge the status quo and bring us closer to a potential cure – all to give more patients hope for the future.
Advancing science for hope
Everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.
